Clinical Development

Translational Medicine Now Bigger and Better at QPS

Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult assays in the initial stages of clinical investigation. But we’ve been investing in additional technical personnel and laboratory capacity for translational medicine at our Flagship Delaware Technology Park facility. And now […]

Translational Medicine Now Bigger and Better at QPS Read More »

QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference

The 2017 Transdermal & Intradermal Drug Delivery Systems conference covering Advanced Design, Development & Delivery of Skin-Mediated Therapies and Vaccines is coming up on September 28-29 at the venerable Racquet Club of Philadelphia. Don’t miss Paul Lehman, VP and Head of Dermal & Transdermal Research Services at QPS, presenting “Evolution of the In Vitro Permeation

QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference Read More »

QPS Study Shows Estetrol Promising for Prostate Cancer Treatment

An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along with acceptable safety parameters. These results suggest that E4 may be suitable for standalone or combination treatment with androgen deprivation therapy (ADT). QPS Netherlands performed the Phase II randomized, double-blind,

QPS Study Shows Estetrol Promising for Prostate Cancer Treatment Read More »

Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability

Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the magazine teams up with Industry Standard Research (ISR). ISR looks at 27 different performance metrics, as rated by decision-making executives at biopharmaceutical companies. “Real customers provide experiential feedback on their involvement

Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability Read More »

QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel

Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if done well, or can create a road full of potholes if managed incorrectly. On April 11th, Barbara Derler, PhD, heading the EU patient recruitment team from the QPS site in

QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel Read More »

QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug

QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug in subjects with advanced prostate carcinoma. The original enrollment goal was 133 patients to be enrolled in approximately 18 months. The QPS Global Clinical Operations team enrolled 137 patients at

QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug Read More »

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!

QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated investigational drug in subjects with advanced prostate carcinoma. The original enrollment goal was 133 patients to be enrolled in approximately 18 months. The QPS Global Clinical Operations team enrolled 137

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe! Read More »

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease

The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias for a six-month public consultation. The EMA considers dementia a key public health priority and sees early stage intervention and prevention of symptomatic disease as particularly worthy goals. This

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease Read More »

Magnesium-Tablet-Form

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database

The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last 100 years in Western countries. For example, in the US it is often below the recommended dietary allowances. Decreased Mg intake and/or low serum Mg have been associated with a number

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database Read More »

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016

On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development and personalized medicine at the Informa-sponsored Early Clinical Development conference, Amba Hotel Marble Arch, London. In her lecture, Professor Diamant will cover the following topics: Definition of a valuable biomarker Which

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016 Read More »

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration

Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled, the investigational site may be located anywhere in the world. This paper will walk you through the three key essential considerations for clinical trials intended to support registration in the

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration Read More »

Scroll to Top